Your browser is no longer supported. Please, upgrade your browser.
ABMD Abiomed, Inc. daily Stock Chart
Abiomed, Inc.
IndexS&P 500 P/E78.32 EPS (ttm)3.48 Insider Own1.40% Shs Outstand45.01M Perf Week1.29%
Market Cap12.09B Forward P/E51.50 EPS next Y5.29 Insider Trans-17.36% Shs Float43.98M Perf Month-10.09%
Income158.70M PEG3.26 EPS next Q0.92 Inst Own98.70% Short Float4.93% Perf Quarter12.79%
Sales798.10M P/S15.15 EPS this Y-21.00% Inst Trans0.42% Short Ratio6.52 Perf Half Y87.70%
Book/sh24.48 P/B11.13 EPS next Y19.76% ROA13.30% Target Price326.40 Perf Year53.16%
Cash/sh9.63 P/C28.30 EPS next 5Y24.00% ROE15.10% 52W Range119.01 - 319.19 Perf YTD59.72%
Dividend- P/FCF50.32 EPS past 5Y10.80% ROI17.90% 52W High-14.64% Beta1.19
Dividend %- Quick Ratio4.80 Sales past 5Y29.60% Gross Margin81.20% 52W Low128.94% ATR10.53
Employees1536 Current Ratio5.60 Sales Q/Q-20.60% Oper. Margin27.30% RSI (14)44.85 Volatility3.21% 4.00%
OptionableYes Debt/Eq0.00 EPS Q/Q-49.20% Profit Margin19.90% Rel Volume0.56 Prev Close273.55
ShortableYes LT Debt/Eq0.00 EarningsAug 06 BMO Payout0.00% Avg Volume332.23K Price272.46
Recom2.30 SMA20-1.88% SMA50-7.20% SMA20026.50% Volume186,192 Change-0.40%
Apr-27-20Downgrade SVB Leerink Outperform → Mkt Perform $175
Feb-12-20Downgrade Morgan Stanley Equal-Weight → Underweight $165
Feb-06-20Resumed BTIG Research Neutral
Oct-29-19Downgrade Raymond James Outperform → Mkt Perform
Aug-02-19Downgrade Morgan Stanley Overweight → Equal-Weight $325 → $215
Aug-02-19Downgrade Guggenheim Buy → Neutral
Aug-01-19Downgrade BTIG Research Buy → Neutral
Nov-07-18Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-02-18Upgrade BTIG Research Neutral → Buy
Jun-22-18Reiterated Piper Jaffray Overweight $360 → $480
Apr-04-18Initiated Goldman Buy $332
Jan-19-18Reiterated Leerink Partners Outperform $200 → $265
Oct-16-17Downgrade BTIG Research Buy → Neutral
Sep-29-17Initiated SunTrust Buy $195
Jun-08-17Resumed William Blair Outperform
Apr-06-17Upgrade Piper Jaffray Neutral → Overweight
Dec-07-16Initiated Guggenheim Buy
Oct-30-15Upgrade Raymond James Mkt Perform → Outperform
Aug-18-15Initiated Sterne Agee CRT Buy $130
Aug-12-15Reiterated The Benchmark Company Buy $96 → $129
Sep-15-20 12:20AM  
Sep-14-20 07:00AM  
Sep-08-20 07:00AM  
Sep-05-20 11:31AM  
Aug-31-20 08:00AM  
Aug-27-20 07:24AM  
Aug-24-20 12:40PM  
Aug-18-20 12:45PM  
Aug-06-20 09:26AM  
Aug-04-20 08:50AM  
Jul-31-20 08:02AM  
Jul-30-20 08:00AM  
Jul-22-20 11:40AM  
Jul-20-20 08:19AM  
Jul-16-20 07:00AM  
Jul-12-20 07:38PM  
Jul-09-20 10:00AM  
Jul-02-20 09:00AM  
Jul-01-20 07:00AM  
Jun-17-20 10:29AM  
Jun-16-20 07:00AM  
Jun-15-20 07:00AM  
Jun-12-20 11:40AM  
Jun-10-20 06:59PM  
Jun-08-20 02:50PM  
Jun-05-20 09:41AM  
Jun-03-20 04:30PM  
Jun-01-20 02:05PM  
May-30-20 11:31AM  
May-27-20 04:30PM  
May-20-20 07:00AM  
May-19-20 09:32AM  
May-15-20 10:38AM  
May-11-20 02:39PM  
May-05-20 10:09AM  
May-03-20 08:06AM  
May-01-20 06:25AM  
Apr-30-20 03:44PM  
Apr-29-20 07:29PM  
Apr-24-20 09:59AM  
Apr-23-20 12:32PM  
Apr-10-20 07:00AM  
Apr-08-20 06:21AM  
Mar-26-20 11:40AM  
Mar-25-20 07:05AM  
Mar-22-20 11:05PM  
Mar-19-20 07:11PM  
Mar-10-20 11:40AM  
Mar-09-20 10:13AM  
Mar-07-20 11:30AM  
Mar-04-20 07:05AM  
Feb-24-20 08:52AM  
Feb-12-20 02:35AM  
Feb-10-20 11:47AM  
Feb-07-20 04:01PM  
Feb-06-20 09:30AM  
Feb-05-20 08:52AM  
Jan-31-20 10:44AM  
Jan-30-20 02:57PM  
Jan-27-20 03:16PM  
Jan-25-20 08:02AM  
Jan-21-20 04:18PM  
Jan-18-20 12:46PM  
Jan-14-20 07:22AM  
Jan-13-20 12:50PM  
Jan-03-20 12:10PM  
Jan-02-20 01:05PM  
Dec-30-19 08:24AM  
Dec-28-19 04:22PM  
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; and Impella Connect, a cloud-based technology that enables secure, cloud-based, and remote viewing of the Automated Impella Controller for physicians and hospital staffs. In addition, the company engages in the development of Impella XR Sheath, a sheath designed to expand and recoil to all for ease of use upon insertion of an Impella heart pump and minimize the size of the arteriotomy; Impella BTR, a percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MINOGUE MICHAEL RChairman, President, CEOAug 21Option Exercise22.4440,000897,600250,746Aug 24 05:45 PM
MINOGUE MICHAEL RChairman, President, CEOAug 21Sale306.3340,00012,253,177210,746Aug 24 05:45 PM
MINOGUE MICHAEL RChairman, President, CEOAug 20Option Exercise22.4460,0001,346,400270,746Aug 24 05:45 PM
MINOGUE MICHAEL RChairman, President, CEOAug 20Sale310.9860,00018,658,744210,746Aug 24 05:45 PM
SUTTER MARTIN PDirectorAug 19Sale312.38750234,285186,260Aug 20 04:40 PM
SUTTER MARTIN PDirectorAug 18Sale311.99750233,993187,760Aug 20 04:40 PM
THOMAS PAULDirectorAug 10Sale303.412,000606,8206,530Aug 11 04:07 PM
PUHY DOROTHY EDirectorJul 15Sale275.007,5002,062,5007,652Jul 17 04:02 PM
PUHY DOROTHY EDirectorJun 05Sale250.007,5001,875,00015,152Jun 09 04:04 PM
SUTTER MARTIN PDirectorMay 04Option Exercise9.9912,000119,880200,939May 06 04:02 PM
SUTTER MARTIN PDirectorMay 04Sale180.5812,0002,166,928188,939May 06 04:02 PM
THOMAS PAULDirectorMar 02Sale151.782,000303,5618,920Mar 04 04:23 PM
THOMAS PAULDirectorFeb 10Sale181.132,000362,25010,920Feb 12 05:14 PM